Miravil (Sertraline)

Sertraline, the active ingredient in Miravil, is a selective serotonin reuptake inhibitor presented as an oral tablet for oral use. It treats major depressive disorder and several anxiety‑related conditions in adult patients.

GNH USA supplies Miravil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Sertraline acts on serotonergic pathways to alleviate mood and anxiety disorders. It is clinically indicated for: - Major depressive disorder: reduces depressive symptoms and improves overall mood. - Obsessive‑compulsive disorder: lessens intrusive thoughts and compulsive behaviors. - Panic disorder: decreases frequency and severity of panic attacks. - Social anxiety disorder: lowers social fear and avoidance. - Post‑traumatic stress disorder: mitigates re‑experiencing and hyper‑arousal symptoms. - Premenstrual dysphoric disorder: eases mood swings and irritability associated with the menstrual cycle.

Sertraline may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: mild stomach upset often occurring early in treatment. - Headache: transient tension‑type headaches. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation. - Diarrhea: loose stools. - Sexual dysfunction: decreased libido or delayed orgasm.

Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Suicidal thoughts: emergence of suicidal ideation, especially in young adults. - Hyponatremia: low blood sodium levels causing confusion. - Bleeding abnormalities: increased risk of gastrointestinal bleeding. - Severe allergic reaction: rash, swelling, or difficulty breathing. - QT prolongation: rare cardiac rhythm disturbances.

Before initiating sertraline therapy, consider the following precautions: - Pregnancy: category B; discuss potential risks with a healthcare professional. - Breastfeeding: evaluate benefits versus potential infant exposure. - Hepatic impairment: dose adjustment may be required in liver disease. - Concomitant MAOI use: avoid due to risk of serotonin syndrome. - Elderly patients: monitor for hyponatremia and falls. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Sertraline can interact with several medication classes. Review patient medication lists carefully.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Pimozide: may cause severe cardiac effects. - Triptans: increased serotonin syndrome risk.

Moderate Interactions (Monitor Closely): - NSAIDs and anticoagulants: heightened bleeding risk. - Antipsychotics (e.g., risperidone): may increase plasma sertraline levels. - CYP2D6 inhibitors (e.g., fluoxetine): can elevate sertraline concentrations.